Presented by the Molecular Medicine Training Program, the MolMed 504 lecture series is open to all interested UW faculty, fellows, students, and staff. 

Challenges in Tuberculosis

April 29, 2019

Willem Hanekom
Bill and Melinda Gates Foundation
"Recent Breakthroughs in TB Vaccine Development"

May 6, 2019

David Sherman
University of Washington
"TB Systems Biology:  Tools to Take On A Killer"

May 13, 2019

Kevin Urdahl
Seattle Children’s
"T cell-mediated immunity in the TB granuloma"

May 20, 2019

Tanya Parish
Infectious Disease Research Institute
"How Biology Informs Tuberculosis Drug Discovery"

Challenges in Cancer Immunotherapy

May 3, 2018

Aude G. Chapuis, MD
Assistant Member, Fred Hutch | Assistant Professor, UW
"Harnessing the Therapeutic Potential of Genetically Modified Transferred T Cells"

May 10, 2018

Martin A. “Mac” Cheever, MD
Director, Cancer Immunotherapy Trials Network | Member, Fred Hutch | Professor, Oncology, UW
"The Dawn of Immune Oncology Dominance: Anti-PD1 and Anti-PD-L1 Therapy"

May 17, 2018

Cameron Turtle, MBBS, PhD
Associate Member, Clinical Research Division, Fred Hutch | Associate Professor, Oncology, UW
"CD19 CAR-T Cell Immunotherapy for B Cell Malignancies"

May 24, 2018

Tina Albertson, MD, PhD
VP, Clinical Development, Juno Therapeutics
"Development of Novel Cancer Therapeutics: A Career Path from Pediatric Oncologist to Industry Physician Scientist"

May 31, 2018

Michael Jensen, MD
Director, Ben Towne Center for Childhood Cancer Research, SCRI | Professor, Heme-Onc, UW | Joint Member, Fred Hutch
"Engineered T Cell Immunity to Cancer"